BRIEF

on PREDILIFE (EPA:ALPRE)

PREDILIFE's semi-annual liquidity contract review as of June 30, 2026

Stock price chart of PREDILIFE (EPA:ALPRE) showing fluctuations.

On July 16, 2026, PREDILIFE, a specialist in disease risk prediction solutions, published the half-year report on its liquidity contract with TSAF - Tradition Securities And Futures. As of June 12, 2026, the liquidity account held 4,731 PREDILIFE shares and €27,793.35. By comparison, it held 5,673 shares and €24,086.30 as of December 31, 2025.

During the first half of 2026, 5,680 shares were purchased for a total of €17,486.61, and 6,622 shares were sold for €21,193.66. These figures illustrate a slight decrease in the number of shares held compared to the previous half of the year.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all PREDILIFE news